The total return over the past 12 months is -73.87% vs. +16.94% for the S&P 500. So far it's up -82.11% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (73.87%) | (21.42%) | (22.79%) | N/A | N/A | N/A |
| Total Return CAGR | (73.87%) | (21.42%) | (22.79%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Compass Therapeutics, Inc. (CMPX)
| Year | Start price | End price | CMPX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.37 | $0.96 | (82.11%) | +14.51% | (96.62%) |
| 2025 | $1.45 | $5.37 | +270.34% | +17.72% | +252.62% |
| 2024 | $1.56 | $1.45 | (7.05%) | +24.89% | (31.94%) |
| 2023 | $5.03 | $1.56 | (68.99%) | +26.19% | (95.18%) |
| 2022 | $3.17 | $5.03 | +58.68% | (18.17%) | +76.85% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
